Comment on AbbVie Spending Historic Amount of Cash to Buy Half of a Cancer Drug

AbbVie Spending Historic Amount of Cash to Buy Half of a Cancer Drug

CHICAGO (TheStreet) -- AbbVie is spending $21 billion to buy half of a cancer drug. That's an extraordinary amount of money even though that cancer drug, Imbruvica, is fantastic and may become one the best-selling of all time. Pharmacyclics developed Imbruvica, which is approved to treat two different types of blood cancer.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News